Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients

British Journal of Radiology

Volumn 85, Issue 1012, 2012, Pages 390-394

  McArthur, Claire ^a   McLaughlin, G ^a   Meddings, R N ^a  

^a AYR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; WHOLE BODY SCINTISCANNING; X RAY;

ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 79960206979     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/79184355     Document Type: Article

References (16)

1. UK. CR. Prostate cancer statistics - key facts. Cancer Research UK site [cited 20 May 2010]. Available from: http://info. cancerresearchuk.org/ cancerstats/types/prostate/
2. Haukaas S, Roervik J,Halvorsen OJ, FoellingM.When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer? Br J Urol 1997;79:770-6. (Pubitemid 28312598)
3. Pal RP, Thiruudaian T, Khan MA. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer? Asian J Androl 2008;10:890-5.
4. Lin K, Szabo Z, Chin BB, Civelek AC. The value of a baseline bone scan in patients with newly diagnosed prostate cancer. Clin Nucl Med 1999;24:579-82. (Pubitemid 29357416)
5. Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka JT, Melhem ER, et al. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 1997;169:1655-61. (Pubitemid 127469800)
6. Sadik M, Suurkula M, Hoglund P, Jarund A, Edenbrandt L. Quality of planar whole-body bone scan interpretations - a nationwide survey. Eur J Nucl Med Mol Imaging 2008;35: 1464-72.
7. Lee N, Fawaaz R, Olsson CA, Benson MC, Petrylak DP, Schiff PB, et al. Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients. Int J Radiat Oncol Biol Phys 2000;48:1443-6.
8. GleaveME, Coupland D, Drachenberg D, Cohen L, Kwong S, Goldenberg SL, et al. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. Urology 1996;47:708-12. (Pubitemid 26172740)
9. Huncharek M, Muscat J. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. Cancer Invest 1995;13:31-5.
10. Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993;269:57-60. (Pubitemid 23006523)
11. Chybowski FM, Keller JJ, Bergstralh EJ, Oesterling JE. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 1991;145:313-18.
12. O'Sullivan JM, Norman AR, Cook GJ, Fisher C, Dearnaley DP. Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. BJU Int 2003;92:685-9. (Pubitemid 37475805)
13. Ayyathurai R, Mahapatra R, Rajasundaram R, Srinivasan V, Archard NP, Toussi H. A study on staging bone scans in newly diagnosed prostate cancer. Urol Int 2006;76:209-12.
14. Briganti A, Passoni N, Ferrari M, Capitanio U, Suardi N, Gallina A, et al. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool. Eur Urol 2009;57:55-8.
15. Heidenreich A, Bolla M, Joniau S, van der Kwast TH, Matveev V, Mason MD, et al. Guidelines on prostate cancer. Arnhem, The Netherlands: European Association of Urology; 2009.
16. Agresti A, Coull BA. Approximate is better than 'exact' for interval estimation of binomial proportions. Am Statist 1998;52:119-26.